Montefiore-Einstein Cancer Center

The Bronx, New York 10467

5 studies enrolling now · 15 studies all time

What they study most

Acute-graft-versus-host Disease, Advanced Lymphoma, Advanced Solid Tumor, Breast Cancer, Cancer, Cholangiocarcinoma, Colorectal Cancer, Colorectal Neoplasms, Graft-versus-host Disease, HIV Infection, Homologous Recombination Deficiency (HRD), KRAS G12C Lung Cancer

Studies at this site

• A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer — Recruiting now
• A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer — Recruiting now
• A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid Tumors — Recruiting now
• First in Human, Dose Escalation Study of AN4005 — Recruiting now
• Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs — Recruiting now
• A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer — Stopped early
• A Study of Cobimetinib Plus Paclitaxel, Cobimetinib Plus Atezolizumab Plus Paclitaxel, or Cobimetinib Plus Atezolizumab Plus Nab-Paclitaxel as Initial Treatment for Participants With Triple-Negative Breast Cancer That Has Spread — Stopped early
• Treatment of Metastatic Castration-Resistant Prostate Cancer With Homologous Recombination Deficiency — Stopped early
• An Open-Label Study of Defibrotide for the Prevention of Acute Graft-versus-Host-Disease (AGvHD) — Completed
• A Study of Atezolizumab Administered Alone or in Combination With Azacitidine in Participants With Myelodysplastic Syndromes — Completed
• Phase 2 Nab® -Paclitaxel (Abraxane®) Plus Gemcitabine in Subjects With Locally Advanced Pancreatic Cancer (LAPC) — Completed
• A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer — Completed
• Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials — Completed
• A Trial of ALB 109564(a) in Subjects With Advanced Solid Tumors — Stopped early
• PK-directed Dose Adjustment of IV Busulfan Conditioning Regimen for Autologous Stem Cell Transplant in Lymphoma Patients — Completed